A new study at UCLH and UCL aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile of their tumour.
Researchers at UCLH, the Francis Crick Institute, and the UCL Cancer Institute have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors.
A UCLH patient has received an innovative treatment for radiotherapy-induced dry mouth, an irreversible serious adverse effect of head and neck cancer radiotherapy that causes permanent impairment of talking and eating.
UCLH has recruited the first participant to a global study of a new drug in early development, which is thought to reduce the production of a protein in the brain called tau.
A new CAR-T therapy has delivered promising results in treating patients with an aggressive blood cancer, in results from a trial led by researchers at UCL and UCLH.
UCL researchers will co-lead a new initiative to reduce maternity inequalities by improving care and support for families before and between pregnancies.
